(MT Newswires) -- Moderna (MRNA) reported fourth-quarter revenue that beat analysts' expectations by gaining Covid vaccine market share on its rival, Pfizer Inc, posting quarterly revenue of $2.8 billion for its Covid-19 vaccine. "We are excited about the future," chief executive officer Stephane Bancel tells Bloomberg Television.

Bloomberg videos